Colorectal neoplasm
Conditions
Interventions
White light imaging without hood group
White light imaging with hood group
Autofluorescence imaging without hood group
Autofluorescence imaging with hood group
Sponsors
Osaka Medical Center for Cancer and Cardiovascular Diseases
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Patients who are undergoing screening colonoscopy for positive fecal occult blood examination, or surveillance colonoscopy after endoscopic resection for colorectal neoplasm. 2)Patients who provided written informed consent
Exclusion criteria
Exclusion criteria: 1)Patients who had previously undergone major surgery. 2)Patients with open bleeding or symptoms suspected colonic stenosis. 3)Patients with inflammatory bowel disease, familial polyposis and known colon neoplasm. 4)Patients who are receiving anticoaglant medication or bleeding tendency. 5)Patients with severe organ failure. 6)Patients without informed consent. 7)Patients who are regarded in-eligible by the doctor who participates in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Neoplasm detection rate | — |
Secondary
| Measure | Time frame |
|---|---|
| Total number of cancers in both group. Total number of depressed/flat/sessile lesions. Total number of hyperplastic polyp. Total number of adenomas less than 5mm. Right-sided versus left-sided location. Total number of adenomas larger than 1cm. Total number of patients with polyps. Total number of patient with adenoma less than 5mm. Procedure time (intubation time and observation time). Adverse event. | — |
Countries
Japan
Contacts
Public ContactYoji Takeuchi
Osaka Medical Center for Cancer and Cardiovascular Diseases Gastrointestinal Oncology
Outcome results
None listed